4SC to Present at Two Upcoming Investor Conferences
4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will be presenting at two investor conferences this week.
Dr Ulrich Dauer, Chief Executive Officer of 4SC AG, will give a company presentation at the Future Leaders in the Biotech Industry conference, which will be held on 20 April 2012 in New York City, USA.
The presentation of 4SC will begin at 9.00am (ET).
Enno Spillner, Chief Financial Officer of 4SC AG, will give a company presentation at the 3rd FCF Family-to-Family Day, an investor conference exclusively for family offices and HNIs (High Net Worth Individuals) on 19 April 2012 in Munich.
The presentation of 4SC will begin at 3.15pm (CET).